Advocate Health names leadership team after Atrium merger

Advocate Health––the newly combined entity of Advocate Aurora Health and Atrium Health––has named its new leadership team.

The two healthcare systems finalized their merger at the beginning of December. The deal brought together Advocate Aurora Health, one of the 12 largest not-for-profit, integrated health systems in the U.S. and a major employer in the Midwest, with 75,000 team members, with Atrium Health, an integrated, nonprofit health system with more than 70,000 teammates, 40 hospitals and 500 care sites.

“Our executive leadership team will chart the course for our journey to reimagine health and well-being, advance health equity and improve the lives of individuals, communities and teammates,” Jim Skogsbergh, who serves as CEO along with Eugene A. Woods as CEO until his retirement in 18 months, said in a statement.

Advocate Health is now the fifth largest nonprofit health system in the United States, serving nearly six million patients in Alabama, Georgia, Illinois, North Carolina, South Carolina and Wisconsin. The health system operates more than 1,000 sites of care and 67 hospitals and employs nearly 150,000.

The new leadership team includes 25 members:

  • Bobbie Byrne, MD, EVP and Chief Information Officer
  • Don Calcagno, SVP, Chief Population Health Officer
  • Kinneil Coltman, DHA, EVP, Chief Community and Social Impact Officer 
  • Anthony C. DeFurio, MBA, MHA, EVP, Chief Financial Officer
  • Brett J. Denton, EVP, Chief Legal Officer
  • Jim Dunn, PhD, DHA, DAST, FACHE, EVP, Chief People and Culture Officer
  • Delvecchio Finley, MPP, FACHE, President, Atrium Health Navicent
  • Julie A. Freischlag, MD, FACS, FRCSEd(Hon), DFSVS, EVP, Chief Academic Officer and CEO, Atrium Health Wake Forest Baptist
  • Cristy Garcia-Thomas, SVP, Chief Diversity, Equity and Inclusion Officer and President, Advocate National Center for Health Equity
  • Kelly Jo Golson, MBA, EVP, Chief Brand, Communications and Consumer Experience Officer
  • Ken D. Haynes, MSHA, MBA, FACHE, President, Advocate Health - Southeast Region
  • Kevin High, MD, President, Atrium Health Wake Forest Baptist
  • Mary Beth Kingston, PhD, RN, FAAN, EVP, Chief Nursing Officer
  • Richard G. (Rick) Klein, EVP, Chief of Staff 
  • Carol A. Lovin, MHSA, MN, EVP, Chief of Staff and Chief Integration Officer 
  • Kristen Morris, SVP, Chief Government Affairs Officer
  • Scott Powder, MBA, President, Advocate Health Enterprises
  • Scott Rissmiller, MD, EVP, Chief Physician Executive
  • William P. (Bill) Santulli, FACHE, President, Advocate Health - Midwest Region
  • Rasu B. Shrestha, MD, MBA, EVP, Chief Innovation and Commercialization Officer
  • Shoeb J. Sitafalwalla, MD, EVP, Chief Strategy Officer
  • Gary Stuck, DO, FAAFP, EVP, Chief Medical Officer
  • Kurt Stuenkel, MBA, MHA, FACHE, President, Atrium Health Floyd
  • Terry G. Williams, DrPH candidate, MBA, SVP, Chief Population Health Officer
  • Meghan Woltman, SVP, Chief Government Affairs Officer 

 

Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.